Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

March
22
2018

Skin Cancer and SRT – Jeff Goldstein Interview

Jeff Goldstein is a double lung transplant recipient and a multiple skin cancer survivor. Transplant recipients are immune compromised and has a pre-disposition to skin cancer. As a Floridian, Jeff spent a lot of time…

March
19
2018

Physician Spotlight – March 2018

Daniel J. Ladd, Jr., DO is the Medical Director and Founder of Tru-Skin Dermatology in Austin, Texas and the 2018 President-Elect of the AOCD. He earned his BA from the University of Texas at Austin…

March
08
2018

Sensus Healthcare to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

BOCA RATON, Fla., March 8, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and multi-platform state…

March
05
2018

Sensus Healthcare Launches New Line of Laser Systems to Provide Patients with Full Spectrum of Clinical and Aesthetic Dermatological Solutions

Lasers Address Acne Lesion Correction, Hair Removal and Tattoo Removal, Among Other Applications BOCA RATON, Fla., March 5, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy